Bureau of Pharma Public Sector Undertakings of India (BPPI) invited applications from eligible Indian citizens for 7 posts of Executive (Personnel), Executive (Procurement) and Office Assistant on Contractual Basis in BPPI. Eligible candidates can appear for the walk-in-interview on 15, and 19 June, 2015.
Important Date
Date of walk-in-interview: 15, and 19 June 2015
Details of Posts
1. Executive (HR): 1 Post
2. Executive (Procurement): 1 Post
3. Office Assistants: 5 Posts
Eligibility Criteria
Educational Qualification
1. Executive (HR): Candidate should have completed Graduation in any discipline preferably post-graduate Diploma/ Degree in Personnel /HR Management with 03 years experience in handling matters related to personnel, HR management, drafting / noting / maintaining of office record files and having good knowledge of working on computers. Work experience in Govt./ PSU would be preferred.
2. Executive (Procurement): Candidate should have completed Graduation in any discipline preferably post-graduate Diploma/ Degree in Management with 03 years experience in handling matters related to Procurement functions. Persons having knowledge of Government procedures / CVC guidelines for procurement preferred.
3. Office Assistants: Candidate should have completed Graduation in any discipline with 2 years experience in drafting / noting / maintaining of office record files and having good knowledge of working on computers. Work experience in Govt./ PSU would be preferred.
Pay Scale
1. Executive (HR): Rs.17,000/- plus conveyance and mobile phone charges reimbursement both together upto 2,500/- per month
2. Executive (Procurement): Rs.17,000/- plus conveyance and mobile phone charges reimbursement both together upto 2,500/- per month
3. Office Assistants: Rs.15,000/- consolidated per month
How to Apply
Interested candidates can appear for the walk-in-interview on 15, and 19 June, 2015 at BPPI headquarters at IDPL Corporate office, IDPL complex, Old Delhi Gurgaon Road, Dundahera, Gurgaon-122016 (HARYANA).
Comments
All Comments (0)
Join the conversation